MedImmune Message Board - Msg: 19521283

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MedImmune

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Aggie who wrote (272)	11/20/2003 9:33:36 AM
From: rkrw	of 416

<<Does anyone get the sense that the analysts doth protest too loudly? Is the degree of verbage about FluMist really warranted?>> I think so. <<I wonder if this is really a way of establishing the institutional entry point for the new year, i.e. drive the price down to get the best value?>> I think medi is doing a good job of that on their own! <<The jump in long term debt in Q3 is what worries me the most.>> They coupon rate was next to nothing and medi is very profitable. They did blunder and use the cv to buy back shares mainly >$30/share. <<FluMist will take hold eventually, they just need to replace the marketing group responsible for the rollout and bring the price down.>> At least for next flu season expectations will be nice and low :-)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next